Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Frara

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Endocrine|May 31, 2018
Primary hyperparathyroidism in prostate cancer: guilty or not guilty?G Mazziotti, S Frara, A Mosca
Pituitary|October 7, 2016
Acromegalic osteopathyG Mazziotti, F Maffezzoni, S Frara, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|October 18, 2016
New medical therapies of acromegalyF Maffezzoni, S Frara, M Doga, et al.
Endocrine|May 28, 2025
Pathophysiology and evaluation of bone health in adrenal diseasesM M Uygur, L di Filippo, S Frara, et al.
Current Diabetes Reports|April 2, 2017
Diabetes in Cushing DiseaseG Mazziotti, A M Formenti, S Frara, et al.
European Journal of Endocrinology|June 7, 2017
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspectsG Mazziotti, A M Formenti, S Frara, et al.
European Journal of Endocrinology|January 9, 2013
The GH-releasing effect of acylated ghrelin in normal subjects is refractory to GH acute auto-feedback but is inhibited after short-term GH administration inducing IGF1 increaseA Benso, E Gramaglia, I Olivetti, et al.
Pituitary|June 4, 2024
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)Andrea Giustina, M M Uygur, S Frara, et al.
Pituitary|January 29, 2025
Medical management pathways for Cushing's disease in pituitary tumors centers of excellence (PTCOEs)A Giustina, M M Uygur, S Frara, et al.
Endocrine|November 8, 2017
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experienceG Mazziotti, A M Formenti, M B Panarotto, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Endocrine|May 31, 2018
Primary hyperparathyroidism in prostate cancer: guilty or not guilty?G Mazziotti, S Frara, A Mosca
Pituitary|October 7, 2016
Acromegalic osteopathyG Mazziotti, F Maffezzoni, S Frara, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|October 18, 2016
New medical therapies of acromegalyF Maffezzoni, S Frara, M Doga, et al.
Endocrine|May 28, 2025
Pathophysiology and evaluation of bone health in adrenal diseasesM M Uygur, L di Filippo, S Frara, et al.
Current Diabetes Reports|April 2, 2017
Diabetes in Cushing DiseaseG Mazziotti, A M Formenti, S Frara, et al.
European Journal of Endocrinology|June 7, 2017
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspectsG Mazziotti, A M Formenti, S Frara, et al.
European Journal of Endocrinology|January 9, 2013
The GH-releasing effect of acylated ghrelin in normal subjects is refractory to GH acute auto-feedback but is inhibited after short-term GH administration inducing IGF1 increaseA Benso, E Gramaglia, I Olivetti, et al.
Pituitary|June 4, 2024
Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE)Andrea Giustina, M M Uygur, S Frara, et al.
Pituitary|January 29, 2025
Medical management pathways for Cushing's disease in pituitary tumors centers of excellence (PTCOEs)A Giustina, M M Uygur, S Frara, et al.
Endocrine|November 8, 2017
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experienceG Mazziotti, A M Formenti, M B Panarotto, et al.
Pageof 2